Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulation
Author: Weber, B.
Emmert, M.
Behr, L.
Schoenauer, R.
Brokopp, C.
Drogemuller, C.
Modregger, P.
Stampanoni, M.
Vats, D.
Rudin, M.
Burzle, W.
Farine, M.
Mazza, E.
Frauenfelder, T.
Zannettino, A.
Zund, G.
Kretschmar, O.
Falk, V.
Hoerstrup, S.
Citation: Biomaterials, 2012; 33(16):4031-4043
Publisher: Elsevier Sci Ltd
Issue Date: 2012
ISSN: 0142-9612
Statement of
Benedikt Weber, Maximilian Y. Emmert, Luc Behr, Roman Schoenauer, Chad Brokopp, Cord Drögemüller, Peter Modregger, Marco Stampanoni, Divya Vats, Markus Rudin, Wilfried Bürzle, Marc Farine, Edoardo Mazza, Thomas Frauenfelder, Andrew C. Zannettino, Gregor Zünd, Oliver Kretschmar, Volkmar Falk, Simon P. Hoerstrup
Abstract: Prenatal heart valve interventions aiming at the early and systematic correction of congenital cardiac malformations represent a promising treatment option in maternal-fetal care. However, definite fetal valve replacements require growing implants adaptive to fetal and postnatal development. The presented study investigates the fetal implantation of prenatally engineered living autologous cell-based heart valves. Autologous amniotic fluid cells (AFCs) were isolated from pregnant sheep between 122 and 128 days of gestation via transuterine sonographic sampling. Stented trileaflet heart valves were fabricated from biodegradable PGA-P4HB composite matrices (n = 9) and seeded with AFCs in vitro. Within the same intervention, tissue engineered heart valves (TEHVs) and unseeded controls were implanted orthotopically into the pulmonary position using an in-utero closed-heart hybrid approach. The transapical valve deployments were successful in all animals with acute survival of 77.8% of fetuses. TEHV in-vivo functionality was assessed using echocardiography as well as angiography. Fetuses were harvested up to 1 week after implantation representing a birth-relevant gestational age. TEHVs showed in vivo functionality with intact valvular integrity and absence of thrombus formation. The presented approach may serve as an experimental basis for future human prenatal cardiac interventions using fully biodegradable autologous cell-based living materials.
Keywords: Amniotic fluid stem cells; Composite matrix; Fetal model; Heart valve; Prenatal intervention; Tissue engineering
Rights: Copyright © 2012 Elsevier Ltd. All rights reserved.
RMID: 0020118177
DOI: 10.1016/j.biomaterials.2011.11.087
Appears in Collections:Medical Sciences publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.